CARP Pharmaceuticals was founded to develop effective, affordable cancer treatments for millions worldwide.

Based in Brisbane at the Translational Research Institute, the CARP team has identified a unique class of broad spectrum anticancer drugs that have the potential to treat a wide range of cancers, including lung, breast, prostate and pancreatic cancers.

For more information please contact us.